Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
Dayson Moreira(City Of Hope National Medical Center), Marcin Kortylewski(City Of Hope National Medical Center)
Cited by 82
Related Papers
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
|Blood|2013|109
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
|Molecular Therapy — Nucleic Acids|2024|31